FDA recall D-0305-2020

Lupin Pharmaceuticals Inc. · Class III · drug

Product

Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10

Reason for recall

Presence of Foreign substance: identified as a dead ant.

Distribution

Product was distributed to major distributors/wholesalers throughout the United States.

Key facts

Status
Terminated
Initiation date
2019-11-01
Report date
2019-11-13
Termination date
2021-03-04
Voluntary/Mandated
Voluntary: Firm initiated
Location
Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0305-2020